BG64835B1 - Метод за производство на метопрололен състав - Google Patents

Метод за производство на метопрололен състав Download PDF

Info

Publication number
BG64835B1
BG64835B1 BG103595A BG10359599A BG64835B1 BG 64835 B1 BG64835 B1 BG 64835B1 BG 103595 A BG103595 A BG 103595A BG 10359599 A BG10359599 A BG 10359599A BG 64835 B1 BG64835 B1 BG 64835B1
Authority
BG
Bulgaria
Prior art keywords
mixing
additives
active ingredient
aqueous solution
metoprolol
Prior art date
Application number
BG103595A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG103595A (en
Inventor
Pawan Seth
Original Assignee
Pharma Pass Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/120,914 external-priority patent/US6048547A/en
Priority claimed from EP98402192A external-priority patent/EP0987020A1/de
Application filed by Pharma Pass Llc filed Critical Pharma Pass Llc
Publication of BG103595A publication Critical patent/BG103595A/xx
Publication of BG64835B1 publication Critical patent/BG64835B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BG103595A 1998-07-22 1999-07-20 Метод за производство на метопрололен състав BG64835B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/120,914 US6048547A (en) 1996-04-15 1998-07-22 Process for manufacturing solid compositions containing polyethylene oxide and an active ingredient
EP98402192A EP0987020A1 (de) 1998-09-04 1998-09-04 Zusammensetzung enthaltend Metoprolol und Verfahren zur Herstellung

Publications (2)

Publication Number Publication Date
BG103595A BG103595A (en) 2000-07-31
BG64835B1 true BG64835B1 (bg) 2006-06-30

Family

ID=26151693

Family Applications (1)

Application Number Title Priority Date Filing Date
BG103595A BG64835B1 (bg) 1998-07-22 1999-07-20 Метод за производство на метопрололен състав

Country Status (11)

Country Link
AT (1) ATE277603T1 (de)
BG (1) BG64835B1 (de)
DE (2) DE974343T1 (de)
EA (1) EA002188B1 (de)
HK (1) HK1024873A1 (de)
HR (1) HRP990230A2 (de)
HU (1) HUP9902351A3 (de)
NO (1) NO993588L (de)
PL (1) PL334592A1 (de)
SK (1) SK284766B6 (de)
YU (1) YU33999A (de)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4343789A (en) * 1979-07-05 1982-08-10 Yamanouchi Pharmaceutical Co., Ltd. Sustained release pharmaceutical composition of solid medical material
EP0277092A1 (de) * 1987-01-14 1988-08-03 Ciba-Geigy Ag Therapeutisches System für schwerlösliche Wirkstoffe
WO1996032097A1 (fr) * 1995-04-14 1996-10-17 Pharma Pass Compositions solides contenant du polyethyleneoxyde et un principe actif non amorphe

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4343789A (en) * 1979-07-05 1982-08-10 Yamanouchi Pharmaceutical Co., Ltd. Sustained release pharmaceutical composition of solid medical material
US4404183A (en) * 1979-07-05 1983-09-13 Yamanouchi Pharmaceutical Co., Ltd. Sustained release pharmaceutical composition of solid medical material
EP0277092A1 (de) * 1987-01-14 1988-08-03 Ciba-Geigy Ag Therapeutisches System für schwerlösliche Wirkstoffe
WO1996032097A1 (fr) * 1995-04-14 1996-10-17 Pharma Pass Compositions solides contenant du polyethyleneoxyde et un principe actif non amorphe

Also Published As

Publication number Publication date
EA002188B1 (ru) 2002-02-28
ATE277603T1 (de) 2004-10-15
NO993588L (no) 2000-01-24
EA199900583A2 (ru) 2000-02-28
SK96599A3 (en) 2000-02-14
HK1024873A1 (en) 2000-10-27
HRP990230A2 (en) 2000-04-30
DE69920590D1 (de) 2004-11-04
NO993588D0 (no) 1999-07-22
PL334592A1 (en) 2000-01-31
SK284766B6 (sk) 2005-11-03
HU9902351D0 (en) 1999-10-28
HUP9902351A2 (hu) 2000-12-28
EA199900583A3 (ru) 2000-06-26
HUP9902351A3 (en) 2001-01-29
YU33999A (sh) 2002-03-18
DE974343T1 (de) 2000-11-02
BG103595A (en) 2000-07-31
DE69920590T2 (de) 2006-04-06

Similar Documents

Publication Publication Date Title
RU2240110C2 (ru) Новый препарат
KR930007245B1 (ko) 서방성 제제의 제조방법
JP2720932B2 (ja) 経口投与用アセトアミノフエン錠剤の製造法及びアセトアミノフエン二層錠剤
DE60210828T2 (de) Pharmazeutische pellets enthaltend tamsulosin sowie deren herstellungsverfahren
CA2556514C (en) Composition for oral administration of tamsulosin hydrochloride and controlled release granule formulation comprising same
EP1830855A1 (de) Feste, oral applizierbare pharmazeutische darreichungsformen enthaltend rivaroxaban mit modifizierter freisetzung
FR2618673A1 (fr) Formule medicamenteuse a liberation controlee
ZA200410386B (en) Medicinal composition for regulating release and process for producing the same
JPS6144811A (ja) 徐放性ジクロフエナクナトリウム製剤
JPH0587488B2 (de)
CZ2006269A3 (cs) Pelety obsahující hydrochlorid venlafaxinu
US5234691A (en) Sustained-release prepararation of basic medical agent hydrochloride
BG64835B1 (bg) Метод за производство на метопрололен състав
RU2140272C1 (ru) Способ получения таблеток натриевой соли фузидовой кислоты без энтеросолюбильного покрытия (варианты), таблетки и гранулят для получения таблеток натриевой соли фузидовой кислоты без энтеросолюбильного покрытия
EP0974343B1 (de) Verfahren zur Herstellung einer festen Zubereitung enthaltend Metoprolol
JPH01156913A (ja) 高薬物含量医薬組成物およびその製造法
KR101175816B1 (ko) 경구 서방성 정제
CZ296274B6 (cs) Neutralizacní komplex arginyl-eprosartan, zpusob jeho prípravy a prostredek
CA2796884A1 (en) Improved controlled release oral dosage form
JPH037220A (ja) アルキルシステインまたはその酸付加塩を含有する安定な錠剤
EP0987020A1 (de) Zusammensetzung enthaltend Metoprolol und Verfahren zur Herstellung
JPH06172161A (ja) 徐放性錠剤
WO2004024138A1 (ja) ジオクチルソジウムスルホサクシネート配合固形製剤
CZ256099A3 (cs) Přípravek na bázi metoprololu a způsob jeho výroby
JPS6024765B2 (ja) セフアレキシンの持続性製剤の製造方法